Anders Olof Adolf Ekblom
Chairman at XSPRAY PHARMA AB
Net worth: 15 334 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Maris Gunars Hartmanis | M | 71 | 13 years | |
| Christine Lind | F | 50 | 9 years | |
| Per Andersson | M | 57 |
XSpray Pharma Futurum AB
| 18 years |
| Mathias Kjellberg | M | 53 |
Modul 1 Data AB
 Modul 1 Data AB Information Technology ServicesTechnology Services Modul 1 Data AB offers consulting and professional services. The firm provides knowledge-specific IT solutions and industry-specific business and eServices. Its IT consulting group develops, provides quality assurance and maintenance of business supporting IT solutions. The company was founded in 1991 and is headquartered in Stockholm, Sweden. | 25 years |
| Uli Alf Hacksell | M | 74 | 6 years | |
| Denise Goode | F | 66 |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | 9 years |
| Bengt Westermark | M | 79 | 7 years | |
| Michael Wyzga | M | 69 | 5 years | |
| Carl-Johan Spak | M | 68 |
Atrogi AB
 Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden.
Flerie Invest AB
 Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | 9 years |
| Jane M. Birgitta Stymne Göransson | F | 67 |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | 9 years |
| Thomas Bengt Eldered | M | 64 |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | - |
| Laura Ila von Schantz | M | 42 | 10 years | |
| Tore Bengtsson | M | - |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 11 years |
| Kerstin Hasselgren | F | 63 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 12 years |
| Denise Scots-Knight | M | 64 | 9 years | |
| Charles Sermon | M | 55 | 9 years | |
| Francesco Gatto | M | - |
Elypta AB
 Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | 7 years |
| Margareta Hagman | F | 58 | 9 years | |
| Michael Owens | M | 68 | 9 years | |
| Marie Svensson | F | 60 | 4 years | |
| Thomas Perlmann | M | - |
Karolinska Institutet
| - |
| Anna Martling | M | 55 |
Karolinska Institutet
| - |
| Hans-Peter Albert Ostler | M | 53 | 3 years | |
| Eva Idén | F | 58 | 7 years | |
| Erik Anders Kronström | M | 57 | 10 years | |
| Andreas Bhagwani | M | 49 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 11 years |
| Peter Ellmark | M | 51 | 6 years | |
| Kristina Sjöblom Nygren | M | 63 | 6 years | |
| Anthon Jahreskog | M | 44 | 7 years | |
| Eva Ulrika Sjökvist Saers | M | 62 | 3 years | |
| Karl Elmqvist | M | - |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | 3 years |
| Staffan Encrantz | M | 73 |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | 2 years |
| Stig Lennart Hansson | M | 68 | 6 years | |
| John P. Richard | M | 66 | 9 years | |
| Klas Kärre | M | 70 |
Karolinska Institutet
| - |
| Jens Nielsen | M | - |
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | 7 years |
| Göran Tornling | M | 77 |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden.
Karolinska Institutet
| - |
| Ulf Ljungberg | M | - |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | 9 years |
| Hans Lennart Rudolf Wigzell | M | 86 |
Karolinska Institutet
| 29 years |
| Gunilla Anders Ekström | M | 66 |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden.
Karolinska Institutet
| 21 years |
| Peter Sjöstrand | M | 78 |
Karolinska Institutet
| - |
| Deepa Pakianathan | M | 59 | 5 years | |
| Susana Borrás | F | - |
Karolinska Institutet
| - |
| Anna-Karin Edstedt Bonamy | M | 50 |
Karolinska Institutet
| 10 years |
| Anders Gabrielsen | M | 58 |
Karolinska Institutet
| - |
| Märta Segerdahl | M | 68 |
Karolinska Institutet
| - |
| Sangwoo Lee | M | 52 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 5 years |
| Alexandra Ekman Ryding | M | - |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 6 years |
| Han Jing Xie | M | 54 |
Karolinska Institutet
| - |
| Matti Sällberg | M | 63 |
Karolinska Institutet
| 24 years |
| Anna-Karin Ekberg | F | - | 2 years | |
| Anders Blanck | M | - |
Karolinska Institutet
| - |
| Karl Bergman | M | - |
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | - |
| Knut Martin Henschen Ingvar | M | 69 |
Karolinska Institutet
| - |
| Peter Hjelmström | M | 51 |
Karolinska Institutet
| - |
| Martin Schalling | M | - |
Karolinska Institutet
| - |
| Caroline Ingre | M | 47 |
Karolinska Institutet
| - |
| Rune Toftgard | M | - |
Karolinska Institutet
| - |
| Petter Brodin | M | - |
Karolinska Institutet
| - |
| Elias Arnér | M | - |
Karolinska Institutet
| - |
| Edvard Smith | M | 73 |
Karolinska Institutet
| - |
| Jan Orwar | M | 60 |
Karolinska Institutet
| - |
| Pär Nordlund | M | 66 |
Karolinska Institutet
| 19 years |
| Gunvor Ester Ekman-Ordeberg | M | 80 |
Karolinska Institutet
| 23 years |
| Mona Ståhle | M | - |
Karolinska Institutet
| - |
| Charlotta Liljebris | M | 60 | 6 years | |
| Lennart Hammarstrom | M | - |
Karolinska Institutet
| - |
| Marie Monika Anna Encrantz | F | - |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | - |
| John Wahren | M | - |
Karolinska Institutet
| - |
| Torgny H. Svensson | M | - |
Karolinska Institutet
| - |
| David Rikard Martinsson Holmdahl | M | 71 |
Karolinska Institutet
| 16 years |
| Sven Fredrik Lindskog | M | 71 |
Karolinska Institutet
| - |
| Roger Glen Berlin | M | 74 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 7 years |
| Lajos Gunnar Németh | M | 72 |
Karolinska Institutet
| 21 years |
| Olle Kämpe | M | 68 |
Karolinska Institutet
| - |
| Andreas Konar | M | 75 | 14 years | |
| Per Magnus Gerde | M | - |
Karolinska Institutet
| - |
| Carola Elisabet Lemne | M | 66 |
Karolinska Institutet
| 26 years |
| Rolf Valter Rikard Kiessling | M | 76 |
Karolinska Institutet
| 30 years |
| Gunnar Magnus Modee Persson | M | 64 |
Karolinska Institutet
| 30 years |
| Erna Möller | F | - |
Karolinska Institutet
| - |
| Rolf Lewensohn | M | - |
Karolinska Institutet
| - |
| Per Axel Tomas Södersten | M | 79 |
Karolinska Institutet
| - |
| Joakim Tedroff | M | 63 |
Karolinska Institutet
| - |
| Lars Olov Larsson | M | - |
Karolinska Institutet
| - |
| Jan-Ingmar Flock | M | 75 |
Karolinska Institutet
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Marie Helena Levander | F | 67 | 6 years | |
| Peter James Arthur Benson | M | 69 | 10 years | |
| Peter John Fellner | M | 80 | 7 years | |
| Gitte Pugholm Aabo | F | 57 |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | 27 years |
| Rein Piir | M | 66 | 17 years | |
| Alastair MacKinnon | M | 53 | 7 years | |
| Niklas Prager | M | 54 | 3 years | |
| Daniel Mackey | M | 50 | - | |
| Catherine Mazzacco | F | 59 |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | 2 years |
| Rolf Classon | M | 79 | 2 years | |
| Gustav Ingemar Kihlström | M | 71 | 6 years | |
| Christina Kassberg | F | 56 | 15 years | |
| Blaise A Coleman | M | 50 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 4 years |
| Erik Bjork | M | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 89 | 89.00% |
| United Kingdom | 10 | 10.00% |
| Denmark | 3 | 3.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Anders Olof Adolf Ekblom
- Personal Network
